Haematologica
HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carretto, E
Right arrow Articles by Bonetti, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carretto, E
Right arrow Articles by Bonetti, F
Haematologica, Vol 85, Issue 11, 1158-1164
Copyright © 2000 by Ferrata Storti Foundation


Case Reports

Vancomycin-resistant Enterococcus faecium infection in three children given allogeneic hematopoietic stem cell transplantation: clinical and microbiologic features

E Carretto, D Barbarini, F Locatelli, E Giraldi, N Pellegrini, L Perversi, P Grossi, P Marone, and F Bonetti

Laboratorio di Batteriologia e Micologia, Laboratori Sperimentali di Ricerca, Area Infettivologica, IRCCS Policlinico San Matteo, viale Taramelli 5, 27100 Pavia, Italy. e.carretto@smatteo.pv.it

BACKGROUND AND OBJECTIVES: The emergence of vancomycin-resistant enterococci (VRE) as nosocomial pathogens is a major problem in the US; in Europe, VRE nosocomial infections are uncommon and only rarely have been reported in Pediatric or Neonatal Units. The aim of this study is to report on the clinical and microbiological features of VRE infections in 3 children given hematopoietic stem cell transplantation (HSCT). PATIENTS AND METHODS: Five episodes of vancomycin-resistant Enterococcus faecium (VREF) infection were diagnosed in 3 children given an allogeneic HSCT. Molecular methods, such as random amplification of polymorphic DNA (RAPD) fingerprinting and automated ribotyping, were used in order to define the circulation of strains. RESULTS: All the isolates were resistant to all commercially available agents and showed the VanA genotypic profile. All children were successfully treated with the combination of quinupristin/dalfopristin (QD) plus teicoplanin (TEC), although treatment was not sufficient to eradicate the micro-organism promptly from the gastrointestinal tract. All our children are still alive. After the first isolation of VRE, a surveillance protocol was started and we documented that the rate of colonization in children and their mothers was less than 1.5%. The RAPD method demonstrated the possible nosocomial transmission of one strain. INTERPRETATION AND CONCLUSIONS: Our experience demonstrates that VRE infection is a life-threatening complication in children given HSCT. Prompt diagnosis of this infection and its treatment with the combination of QD and TEC can successfully manage this severe infection in profoundly immunocompromised patients.


This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
S. Brisse, V. Fussing, B. Ridwan, J. Verhoef, and R. J. L. Willems
Automated Ribotyping of Vancomycin-Resistant Enterococcus faecium Isolates
J. Clin. Microbiol., June 1, 2002; 40(6): 1977 - 1984.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS
Copyright © 2000 by the Ferrata Storti Foundation.